All News

The newly FDA-cleared PACS Viewer from CliniComp reportedly allows direct review and analysis of imaging within a patient’s chart.

In a recent interview, Nina Kottler, MD, offered her perspective on findings from a recent report on AI in health care, AI integration challenges and what the future holds with AI in radiology.

In comparison to everolimus, the peptide receptor radionuclide therapy (177Lu)Lu-edotreotide provided over a nine month longer median progression-free survival for patients with gastroenteropancreatic neuroendocrine tumours (GEP NETs), according to new phase 3 research.

In an amusing take on the subject, this author suggests that having a colleague with dedicated expertise in curtailing unnecessary imaging requests could have an impact in reducing burgeoning worklists.

Catch up on the top radiology content of the past week.

For patients with known or suspected neuroendocrine tumors, the radiopharmaceutical 64Cu-SARTATE offered over 50 percent higher average detection of liver foci than 68Ga-DOTATATE at four hours and 20 hours post-injection, according to research presented at the recent SNMMI conference.

In a recent interview, Amy Patel, MD, discussed recent research on breast cancer screening, pertinent obstacles and keys to facilitating improved adherence with mammography screening.

While acknowledging key limitations, the authors of a new literature review noted that contrast-enhanced mammography offers a viable alternative to conventional imaging and breast MRI for preoperative tumor evaluation and may have a significant impact on surgical management.

Emerging research demonstrates that those with total plaque volume > 750 mm3 have an 18.6 percent risk of MACE at four years in comparison to a 1.4 percent MACE risk for those with no plaque.

In comparison to the 2009 International Federation of Gynecology and Obstetrics (FIGO) staging system for endometrial cancer, researchers found that the updated 2023 FIGO system had over a 17 percent decrease for substage agreement between pelvic MRI and pathology findings.

The Mammomat B.brilliant’s ClearCEM image reconstruction technique reportedly utilizes advanced algorithms to facilitate improved noise reduction and lesion enhancement.

Catch up on the most-well viewed radiology content in June 2026.

In recent interviews with Diagnostic Imaging, Jeremie Calais, MD, PhD, Michael Hofman, MBBS, FRACP, Heather Jacene, MD, Phillip Kuo, MD, and more shared their thoughts about the potential impact of theranostics and what excites them about the future of nuclear medicine.

Catch up on the most well-viewed video interviews from Diagnostic Imaging in June 2026.

In order to fully take advantage of the capabilities of AI, this author emphasizes key principles and a framework for converting isolated technology solutions into reliable components of radiology workflows and operations.

The words you say, how you say them and the tone in which you say them may impact perceptions of your credibility.

Catch up on a variety of FDA news in radiology from the past week.

Catch up on the top radiology content of the past week.

Catch up on recent interviews with Michael Hofman, MBBS, FRACP, Heather Jacene, MD, Phillip Kuo, MD, and more discussing new research and advances presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2026 conference.

Researchers found that non-contrast head CT exams, head and neck CT exams and spine CT imaging increased by 33 percent, 76.9 percent and 52.9 percent, respectively, per 1,000 emergency department encounters over the last decade.

The new functionalities for the AI-enabled Breast Suite software include automated identification of breast arterial calcifications and integration of prior mammograms.

Catch up on the top AI-related news and research in radiology over the past month.

The First Read software provides preliminary drafting of radiology reports based on AI assessment of chest X-rays.

The Oncology Virtual Expert AI software reportedly provides semi-automated segmentation maps of brain tumors based on standard brain MRI scans.

In a recent interview discussing the SNMMI conference, Jeremie Calais, MD, PhD, shared his thoughts on emerging advances. a key mentor in nuclear medicine and combination therapy for prostate cancer.

The newly launched HOPPR Presto Agent reporting platform can be integrated into existing radiology systems and AI models without the need for new software.

In a recent interview, Constance Lehman, MD, PhD, discussed newly published research demonstrating the dynamic capability of AI-based risk scores, drawn from screening mammograms, to facilitate risk-adaptive screening.

In a recent episode of our “Molecular Imaging in Focus” series, Surekha Yadav, MBBS, MD, discussed research presented at the SNMMI conference that showed significant advantages of PSMA PET over conventional imaging for detection of osseous oligometastatic prostate cancer (PCa).